Tag Archives: mu variant

Coronavirus Updates: Restrictions to be lifted on fully-vaccinated, non-American travelers Monday

NEW YORK (WABC) — The U.S. is lifting restrictions on foreign travelers who are fully vaccinated against COVID, starting Monday.

The Biden administration is expecting long lines and delays at airports with travelers possibly pouring into the states.

When the announcement was made, online searches for international flights jumped 338%.

Delta Airlines saw bookings shoot up by 450%, and United Airlines says it will be bringing 30,000 travelers into the U.S. on Monday alone.

Here are more of today’s COVID-19 headlines:

Novavax says its vaccine could win over skeptics

The biotechnology company Novavax plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine, CEO Stanley Erck told CNN in a phone interview Friday. Novavax’s vaccine, called NVX-CoV2373, is made using somewhat more conventional methods than the vaccines already authorized for use in the US.

US cancels vaccine maker’s multimillion dollar deal
The federal government has canceled a multimillion dollar deal with Emergent BioSolutions, a Maryland-based vaccine manufacturer with facilities in Baltimore that were found to have produced millions of contaminated Johnson & Johnson vaccine doses this spring, the Washington Post reported. Emergent disclosed the development Thursday in a conference call discussing its latest financial results, the Post reported. Emergent said it will forgo about $180 million due to the contract’s termination, according to the Post. Emergent BioSolutions played a role in the Trump administration’s effort to speed up vaccine development and distribution. But after winning a contract from the previous administration, Emergent quickly ran into production problems. In March, ingredients intended for use in producing the Oxford-AstraZeneca vaccine shots contaminated 15 million doses of the Johnson & Johnson vaccine. The problems with the vaccines caused a monthslong delay in production. After that, the Biden administration put Johnson & Johnson in direct control of vaccine production there.

15 unions reach COVID vaccine mandate deal with NYC, talks continue with outliers
New York City employees who don’t want to get vaccinated have until Friday to file for a religious or medical exemption if they have any hope of staying on the payroll, this as the city announces more deals with unions representing municipal workers. Mayor Bill de Blasio said Friday that 15 unions, including city’s largest, DC 37, have signed onto the deal. The unions represent more than 100,000 city workers covered by this most recent mandate that took effect last week, but the police and fire unions are not included and are still trying to hash out their own deals. Around 92% of city workers under the mandate are vaccinated, including 90% of EMS, 79% of firefighters, 85% of sanitation workers, and 85% of NYPD employees.

COVID vaccine refusal 10th highest reason for job cuts in 2021, report says
While experts say we’re still in the so-called “Great Resignation,” a recent Jobs Cut Report uncovered vaccine refusal as the 10th highest reason for job cuts this year. Numbers released by Chicago-based outplacement and business and executive coaching firm Challenger, Gray & Christmas, Inc. came on on the same day President Biden announced new federal guidance and deadline for tens of millions of workers to get vaccinated.
“Roughly 5,000 people that lost their jobs in the last month due to COVID vaccine refusal made up actually 22% of the total number of people that we tracked being let go across the country,” the firm’s Senior VP Andy Challenger told our sister station KGO-TV.

Pfizer’s COVID-19 pill reduces risk of being hospitalized or dying by 89%, company says

A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results released Friday by the pharmaceutical company. In a study of more than 1,200 COVID-19 patients with a higher risk of developing serious illness, people who took Pfizer’s pills were far less likely to end up in the hospital compared to people who got placebo pills. None of the people who got the real pills died, but 10 people who got placebo pills died, according to results summarized in a Pfizer press release.
SantaCon returns
After taking a year off due to the pandemic, SantaCon is returning to New York City. The event requires a $13 donation for all-inclusive Santa Badge access to the official SantaCon venues. The location of a Yuletide kickoff party won’t be disclosed until closer to the December 11 SantaCon date.

Turkey Day troubles? Smaller birds, popular Thanksgiving sides could be harder to find in 2021
Consumers may have to trim their list of trimmings for their highly anticipated Thanksgiving meal this year. Top turkey seller Butterball said it doesn’t expect an overall gobbler shortage, but that those in search of a smaller size bird could have a hard time.
“Typically a 10- to 12-pound (turkey) up to 14 pounds is going to be more difficult,” Butterball CEO Jay Jandrain told “Good Morning America” on Friday. “Anything over 16 pounds, they’ll certainly be more readily available.”

Q&A: What to know about COVID-19 vaccines for kids aged 5-11
Vaccinations finally are available to U.S. children as young as 5, to the relief of some parents even as others have questions or fears. Late Tuesday, the Centers for Disease Control and Prevention gave the final OK for youngsters age 5 to 11 to get kid-size doses of the vaccine made by Pfizer and its partner BioNTech. Pediatricians and other doctors’ groups praised the move and are gearing up to help families decide whether to vaccinate their children. The shots could be available as soon as Wednesday and will be offered at pediatricians offices, clinics and pharmacies. Like COVID-19 vaccines for adults, they are free. Here’s everything you need to know.

Will the supply chain issues impact holiday shopping? Here’s what the experts say

With the holiday shopping suddenly upon us, it appears that getting that perfect gift or preparing that perfect meal will be far more challenging than in years past due to supply chain issues. Shoppers are noticing that it’s difficult to find a variety of items, and virtually everything from food to Christmas trees are more expensive. The price increase is being caused by gridlock at major seaports and a truck driver shortage across the country. Analysts say the forecast for the holiday season is not looking better.

MORE CORONAVIRUS COVID-19 COVERAGE

New York City COVID-19 Vaccine Tracker
New Jersey COVID-19 Vaccine Tracker
Centers for Disease Control and Prevention on coronavirus

Submit a News Tip or Question

“9

Copyright © 2021 WABC-TV. All Rights Reserved.



Read original article here

Coronavirus: 53 cases of new R.1 variant detected in California. Here’s what to know about the mutated COVID strain

SAN FRANCISCO — The R1 variant is the new strain of COVID-19 researchers are keeping a close eye on. The CDC identified “multiple spike protein mutations” in this variant.

“The R.1 variant does carry some mutations that allow it to be less susceptible to the vaccine,” said Dr. Joe DeRisi, professor of biochemistry and biophysics at UCSF and co-president of Chan Zuckerberg Biohub.

Derisi’s team at Biohub is actively sequencing COVID variants.

“The Delta variant has quite a few more additional mutations in the spike protein that allows it to spread faster,” DeRisi said when asked how the Delta variant compares with the R.1 variant.

The R.1 variant has mutations that were found in the Gamma and Beta variants.

“While it does have some of those worrisome mutations it doesn’t have any more mutations than what we’ve seen before,” said DeRisi.

According to the CDC, the first cases of the R.1 variant in the U.S were detected at a nursing facility in Kentucky where both vaccinated and unvaccinated residents were infected. Meaning this variant has the capability to evade the antibodies produced by the vaccine.

“The virus is evolving to infect better human cells and to transmit better in the human population,” said Lorena Zuliani-Alvarez, PhD principal investigator for UCSF’s QBI.

So far 2,282 cases of the R.1 variant have been detected in the U.S since March.

The latest data aggregated by scientists worldwide on the outbreak.info data base, points to 53 cases in California.

Zuliani-Alvarez says they are waiting on more data to understand the power of the R.1 variant.

“What we have to monitor and check is how well these adaptations are happening,” said Zuliani-Alvarez

As it stands now, the Delta variant is the main variant of concern.

It has mutated more than 20 times and continues to be the dominant variant across the U.S.

The R.1 variant proves that mutations will continue to take place. The most effective way to stop these mutations from happening is to get vaccinated.

VACCINE TRACKER: How California is doing, when you can get a coronavirus vaccine

Having trouble loading the tracker above? Click here to open it in a new window.

Copyright © 2021 KGO-TV. All Rights Reserved.



Read original article here

DOH Updates: Today’s COVID Count, Pediatric Cases, Mu Variant, and Boosters

State Epidemiologist Dr. Sarah Kemble. PC: state Department of Health.

Hawaiʻi State Epidemiologist Dr. Sarah Kemble answered media questions on Tuesday afternoon about today’s COVID-19 count, pediatric and breakthrough cases, the mu variant and booster shots. During a brief Zoom update, state health officials provided some updates on what we’re seeing now and what we can expect in the weeks ahead.

What today’s case count tells us:

There were 499 additional COVID-19 cases in Hawai‘i on Tuesday. The latest data represents a total of 11,265 “active” cases over two weeks.

“Today our daily new cases seven-day average is at 706–this may indicate a slight reprieve in the numbers that we’ve seen, but we’re definitely not out of the woods yet,” said state epidemiologist Dr. Sarah Kemble. “We are continuing to see very high numbers of cases. Remember that a month ago, 700 would be an incredibly alarming case count for our islands. We also know that there is a lag still, between when we see cases, and when we see hospitalizations and deaths. And tragically, we do anticipate seeing many more deaths reported out in the coming weeks from the cases that we’ve already learned about.”

“The hospitals, as you know, continue to address critical issues with shortages, whether it’s addressing a shortage in oxygen last week, shortages in beds, and continuing to try to provide excellent care to those patients who are coming into our hospitals,” said Dr. Kemble.

“Another factor that we have to consider is some variations in testing from time to time. So, holiday weekend–I’m not sure that people were out in droves to test as they might have during other times. So I think we really need to see how things unfold in the coming week before drawing conclusions about where the case numbers are,” said Dr. Kemble.

ARTICLE CONTINUES BELOW AD

“In the meantime, I do hope that people will have taken to heart the mitigation guidance about keeping in your households, avoiding large gatherings, staying home when you’re sick, and if we can continue to do that, we could see a true decrease in the case trends, which is going to be much needed,” said Dr. Kemble.

Pediatric Cases :

ARTICLE CONTINUES BELOW AD

“We are seeing more cases now than ever among pediatric populations. About a quarter of our cases at last look. Part of that is related to the overall rise in cases. So as the total number cases go up, we’re going to see more children who are diagnosed and who ultimately end up in the hospital, just because the overall numbers are increasing. But we’re also seeing that creeping up a little bit, as a proportion of all cases. This may be partly driven by vaccine because the groups that are left that don’t have eligibility for vaccination are our youngest children. So we are seeing some increase in proportion in cases in that group, which is our unprotected group,” said Dr. Kemble.

“When we do try to look at the severity of illness, we’re still tracking what the national case hospitalization proportion has been, about 2%–that’s still what we’re seeing in Hawaiʻi too. So we aren’t seeing an increase in severity of illness among these pediatric cases, but we are seeing more children infected,” said Dr. Kemble.

Since the start of the pandemic there has been just one pediatric COVID-19 death in Hawaiʻi. In April, 2021, we reported a death involving a boy between 0 and 10 years old who experienced COVID-19 symptoms shortly after arriving in the islands. He had known underlying health conditions and was visiting Hawai‘i with his parents from another state.Both parents were fully vaccinated before making the trip to Hawai‘i.

Breakthrough Cases:

ARTICLE CONTINUES BELOW AD

As of Aug. 26, the state Department of health had documented 2,419 breakthrough cases in Hawaiʻi. “This makes up about 7% of all COVID cases in the state since January, and about 0.3% of the fully vaccinated population,” said Dr. Kemble.

“Part of how we ascertain breakthrough cases is by case investigation. We have to call people and ask them if they’ve been vaccinated. So this is likely an undercount of the true numbers, because we don’t reach everyone to find out that information. But we do have a better look at it when we look at who is in the hospital because usually those people have their vaccine records reviewed. So we do hear from the hospitals and we’re seeing maybe 10% to sometimes 15% of those in the hospital who are vaccine breakthrough cases,” said Dr. Kemble.

“I think there’s a couple of things that you have to keep in mind when you think about vaccine breakthrough cases. One is the more we have infection circulating around us, the more breakthrough cases we will see because while we do know that vaccines work–they’re highly effective at preventing hospitalization and death–they don’t prevent every infection from occurring,” said Dr. Kemble. “And if you have enough infection pressure around you because you’re surrounded by infected people, you will have some of those breakthrough cases. Where we tend to see more of the hospitalizations are in older individuals and those with multiple co-morbidities. These are people who might land in the hospital after getting the common cold sometimes or other common viruses like influenza. So, some of that is to be expected even though it is unfortunate.”

Mu Variant:

“We have had a few cases of mu variant here in Hawaiʻi detected through our whole genome sequencing program with the state Laboratories Division. Also, those were detected back in June. Similar to other jurisdictions that have seen mu, we saw a few cases during that summer time period that seemed to have subsided at this point. We’re not seeing continued detection in the most recent runs. Mu has not been called out by the CDC at this point as a variant of concern. It’s not one of the ones that we have tracked on the variant report, which is why you may not have seen it there,” said Dr. Kemble.

“Part of what make a variant a variant of concern, is not just the characteristics about that particular strain, but also what’s the propensity of that strain to take over and become the dominant strain,” said Dr. Kemble. “We’re not seeing that with mu. We’re really seeing that delta seems to have found its niche here and that’s still well over 95% of the cases that we’re seeing in the state. So our current problems are really driven by delta, not mu.”

Booster Shots:

“Right now, booster shots are something that we’re trying to distinguish from the third dose that you would give to an immunocompromised individual. The ACIP–the Advisory Committee on Immunization Practices–has come out with recommendations that if you are severely immunocompromised– if you have cancer and are on chemotherapy, if you’re taking really high dose steroids every day, certain conditions that would make it difficult for your body to mount the initial immune response–three doses is recommended instead of two,” said Dr. Kemble, noting that’s the only current recommendation for additional doses beyond the two dose series for mRNA vaccine.

“For booster shots, we are all awaiting further review of the data and Emergency Use Authorization from the FDA before providing recommendations on boosters for the general population,” said Dr. Kemble. “There’s a couple of reasons why I wouldn’t recommend running out today to get your booster shot. One is that we still don’t have great information on when to get it, what the impact’s going to be, which populations are going to benefit from it. There’s a lot of unknowns out there that we still don’t know about boosters.”

“What we do know right now is that if you haven’t had a single shot of vaccine, you will greatly benefit by getting that full series done now,” said Dr. Kemble, saying the unvaccinated population is a first priority for vaccinations.



Read original article here